Search our database to locate a facility in your area that has PRAXBIND available.
Search our database to locate a facility in your area that has PRAXBIND available.
*Accurate as of 01/03/20. Boehringer Ingelheim Pharmaceuticals, Inc. cannot guarantee the availability of PRAXBIND at the facilities listed on this page. Based on the most current information available to Boehringer Ingelheim Pharmaceuticals, Inc., these institutions have purchased PRAXBIND.
Reference: 1. Data on file. Boehringer Ingelheim Pharmaceuticals, Inc.
Praxbind® (idarucizumab) is indicated in patients treated with Pradaxa® when reversal of the anticoagulant effects of dabigatran is needed:
CL-PB-100001 April 2018
Please click here for full Prescribing Information for PRAXBIND.